Get started
INOVIO PHARMACEUTIINOVIO PHARMACEUTIINOVIO PHARMACEUTI

INOVIO PHARMACEUTI

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals

GBM chart


Full chart

GBM upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪63.07 M‬ CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.821 CHF
Net income (FY)
‪−97.41 M‬ CHF
Revenue (FY)
‪197.76 K‬ CHF
Shares float
‪36.42 M‬
Beta (1Y)
1.71

Employees


Employees (FY)
134
Change (1Y)
+12 +9.84%
Revenue / Employee (1Y)
‪1.48 K‬ CHF
Net income / Employee (1Y)
‪−726.93 K‬ CHF

About Inovio Pharmaceuticals, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Jacqueline E. Shea
Website
inovio.com
Headquarters
Plymouth Meeting
Founded
1983
FIGI
BBG00LVDLC19
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

GBM news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as GBM.

Frequently Asked Questions


The current price of GBM is 1.591 CHF — it has decreased by −10.52% in the past 24 hours. Watch INOVIO PHARMACEUTI stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange INOVIO PHARMACEUTI stocks are traded under the ticker GBM.
GBM stock has fallen by −10.52% compared to the previous week, the month change is a −10.52% fall, over the last year INOVIO PHARMACEUTI has showed a −86.38% decrease.
We've gathered analysts' opinions on INOVIO PHARMACEUTI future price: according to them, GBM price has a max estimate of 10.97 CHF and a min estimate of 1.69 CHF. Watch GBM chart and read a more detailed INOVIO PHARMACEUTI stock forecast: see what analysts think of INOVIO PHARMACEUTI and suggest that you do with its stocks.
GBM reached its all-time high on Mar 26, 2024 with the price of 11.682 CHF, and its all-time low was 1.591 CHF and was reached on May 14, 2025. View more price dynamics on GBM chart.
See other stocks reaching their highest and lowest prices.
GBM stock is 11.75% volatile and has beta coefficient of 1.71. Track INOVIO PHARMACEUTI stock price on the chart and check out the list of the most volatile stocks — is INOVIO PHARMACEUTI there?
Today INOVIO PHARMACEUTI has the market capitalization of ‪63.07 M‬, it has increased by 10.96% over the last week.
Yes, you can track INOVIO PHARMACEUTI financials in yearly and quarterly reports right on TradingView.
INOVIO PHARMACEUTI is going to release the next earnings report on Aug 6, 2025. Keep track of upcoming events with our Earnings Calendar.
GBM earnings for the last quarter are −0.45 CHF per share, whereas the estimation was −0.61 CHF resulting in a 26.30% surprise. The estimated earnings for the next quarter are −0.51 CHF per share. See more details about INOVIO PHARMACEUTI earnings.
INOVIO PHARMACEUTI revenue for the last quarter amounts to ‪57.84 K‬ CHF, despite the estimated figure of ‪11.07 K‬ CHF. In the next quarter, revenue is expected to reach ‪8.39 K‬ CHF.
GBM net income for the last quarter is ‪−17.43 M‬ CHF, while the quarter before that showed ‪−17.60 M‬ CHF of net income which accounts for 0.95% change. Track more INOVIO PHARMACEUTI financial stats to get the full picture.
No, GBM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 18, 2025, the company has 134 employees. See our rating of the largest employees — is INOVIO PHARMACEUTI on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INOVIO PHARMACEUTI EBITDA is ‪−91.05 M‬ CHF, and current EBITDA margin is ‪−50.91 K‬%. See more stats in INOVIO PHARMACEUTI financial statements.
Like other stocks, GBM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INOVIO PHARMACEUTI stock right from TradingView charts — choose your broker and connect to your account.